These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9828103)
1. Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness. Kim K; Daniels KJ; Hay ED Exp Cell Res; 1998 Nov; 245(1):79-90. PubMed ID: 9828103 [TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function. Kim K; Lee KY Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329 [TBL] [Abstract][Full Text] [Related]
3. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243 [TBL] [Abstract][Full Text] [Related]
4. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523 [TBL] [Abstract][Full Text] [Related]
5. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription. Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482 [TBL] [Abstract][Full Text] [Related]
6. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519 [TBL] [Abstract][Full Text] [Related]
7. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242 [TBL] [Abstract][Full Text] [Related]
9. Taxol reduces cytosolic E-cadherin and beta-catenin levels in nasopharyngeal carcinoma cell line TW-039: cross-talk between the microtubule- and actin-based cytoskeletons. Lou PJ; Chen WP; Lin CT; Chen HC; Wu JC J Cell Biochem; 2000 Sep; 79(4):542-56. PubMed ID: 10996845 [TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis. Bagnato A; Rosanò L Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812 [TBL] [Abstract][Full Text] [Related]
12. Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse. Moran AE; Carothers AM; Weyant MJ; Redston M; Bertagnolli MM Cancer Res; 2005 Feb; 65(3):1097-104. PubMed ID: 15705912 [TBL] [Abstract][Full Text] [Related]
13. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921 [TBL] [Abstract][Full Text] [Related]
14. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126 [TBL] [Abstract][Full Text] [Related]
15. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells. Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122 [TBL] [Abstract][Full Text] [Related]
16. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers. Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307 [TBL] [Abstract][Full Text] [Related]
17. Turn-off, drop-out: functional state switching of cadherins. Lilien J; Balsamo J; Arregui C; Xu G Dev Dyn; 2002 May; 224(1):18-29. PubMed ID: 11984870 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420 [TBL] [Abstract][Full Text] [Related]
19. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation. Hildesheim J; Belova GI; Tyner SD; Zhou X; Vardanian L; Fornace AJ Oncogene; 2004 Mar; 23(10):1829-37. PubMed ID: 14647429 [TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Murata-Kamiya N; Kurashima Y; Teishikata Y; Yamahashi Y; Saito Y; Higashi H; Aburatani H; Akiyama T; Peek RM; Azuma T; Hatakeyama M Oncogene; 2007 Jul; 26(32):4617-26. PubMed ID: 17237808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]